These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6409111)

  • 1. Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin.
    Chaudhry PS; Cabrera J; Juliani HR; Varma SD
    Biochem Pharmacol; 1983 Jul; 32(13):1995-8. PubMed ID: 6409111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of bovine lens aldose reductase by Clinoril, its absorption into the human red cell and its effect on human red cell aldose reductase activity.
    Crabbe MJ; Freeman G; Halder AB; Bron AJ
    Ophthalmic Res; 1985; 17(2):85-9. PubMed ID: 3920599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac.
    Sharma YR; Cotlier E
    Exp Eye Res; 1982 Jul; 35(1):21-7. PubMed ID: 6807700
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of aldose reductases from rat and bovine lenses by flavonoids.
    Okuda J; Miwa I; Inagaki K; Horie T; Nakayama M
    Biochem Pharmacol; 1982 Dec; 31(23):3807-22. PubMed ID: 6818971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis sativa L. (marijuana) IX: Lens aldose reductase inhibitory activity of marijuana flavone C-glycosides.
    Segelman AB; Segelman FP; Varma SD; Wagner H; Seligmann O
    J Pharm Sci; 1977 Sep; 66(9):1358-9. PubMed ID: 409835
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors.
    Srivastava SK; Petrash JM; Sadana IJ; Ansari NH; Partridge CA
    Curr Eye Res; 1982-1983; 2(6):407-10. PubMed ID: 6820339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of rat lens aldose reductase by flavonoids-matteucinol and baicalein].
    Li SZ; Mao WS; Du XY; Liang SW; Hu BR; Ma YQ
    Yan Ke Xue Bao; 1987 Jun; 3(2):93-4, 137. PubMed ID: 3149594
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-activity correlation of flavonoids for inhibition of bovine lens aldose reductase.
    Iinuma M; Tanaka T; Mizuno M; Katsuzaki T; Ogawa H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1813-5. PubMed ID: 2509087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of aldose reductase from the rat lens by flavonoids].
    Xie MZ; Shen ZF
    Yao Xue Xue Bao; 1986 Oct; 21(10):721-4. PubMed ID: 3107341
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of lens aldose reductase by Labiatae flavonoids.
    Tomás-Barberán FA; López-Gómez C; Villar A; Tomás-Lorente F
    Planta Med; 1986 Jun; (3):239-40. PubMed ID: 3092256
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aldose reductase by 3',4'-dihydroxyflavones.
    Okuda J; Miwa I; Inagaki K; Horie T; Nakayama M
    Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):767-72. PubMed ID: 6428761
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity.
    Matsuda H; Morikawa T; Toguchida I; Yoshikawa M
    Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):788-95. PubMed ID: 12045333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Substrate specificity and inhibition by various compounds of aldose reductase II from rabbit lens].
    Tanimoto T; Fukuda H; Kawamura J
    Yakugaku Zasshi; 1984 Jun; 104(6):631-4. PubMed ID: 6438300
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-ray affinity and photoaffinity inhibitor of aldose reductase.
    Cohen W; Chau SV; Kastl PR; Caldwell DR
    J Ocul Pharmacol; 1986; 2(2):151-8. PubMed ID: 3139807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase inhibitors: flavonoids, alkaloids, acetophenones, benzophenones, and spirohydantoins of chroman.
    Nakai N; Fujii Y; Kobashi K; Nomura K
    Arch Biochem Biophys; 1985 Jun; 239(2):491-6. PubMed ID: 2988452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4h-chromen ring system.
    Kador PF; Sharpless NE
    Biophys Chem; 1978 Mar; 8(1):81-5. PubMed ID: 417745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.